Clinical Trial Update: Bomedemstat (IMG-7289) Plus Ruxolitinib for Myelofibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating Bomedemstat (IMG-7289) in combination with Ruxolitinib for myelofibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Bomedemstat (bomedemstat)
• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: The University of Hong Kong | Conditions: Myelofibrosis | Phase 2 | Status: UNKNOWN